Tag: Route 92 Medical
Route 92 completes enrolment in 250-patient SUMMIT MAX trial
Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...
Route 92 announces 100th patent for its neurovascular intervention portfolio
Route 92 Medical has announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio, as per a press release. The...
Route 92 raises more than US$31 million in oversubscribed Series F...
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of...
Route 92 announces positive clinical findings with Tenzing 7 delivery catheter
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a...
Route 92 Medical announces appointment of Jonathan Kennedy as chief financial...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible...
Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....
Route 92 gains US FDA clearance for complete stroke treatment system
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...
Route 92 announces 80th patent for Monopoint operating platform
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is...
Route 92 Medical announces expansion to new manufacturing site in Utah
Route 92 Medical has announced its expansion to a new high-volume manufacturing site in Salt Lake City, USA. This 40,000-square-foot site will allow Route...
Route 92’s Monopoint operating platform shows 82% first-pass effect in independent...
Route 92 Medical recently announced the publication of an investigator-initiated, multicentre SLIC (Super large-bore ingestion of clot) study of its proprietary Monopoint operating platform,...
Route 92 publishes data demonstrating 80% first-pass effect with novel thrombectomy...
Route 92 Medical has announced the publication of initial results from the SUMMIT NZ clinical trial—a single-arm, multicentre, prospective trial evaluating its proprietary Monopoint...
Route 92 Medical announces first patient enrolment in SUMMIT MAX pivotal...
Route 92 Medical has announced the first patient enrolment in its SUMMIT MAX clinical trial—a randomised, controlled, multicentre study to evaluate the performance of...
